|
CA2876946A1
|
|
A syringe with a hollow plunger
|
|
EP2638896A1
|
|
Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood
|
|
AU2012213378A1
|
|
A syringe
|
|
WO2013037396A1
|
|
Solution of polymer in api for a solid dosage form
|
|
US2011142905A1
|
|
Coated tablets with remaining degradation surface over the time
|
|
WO2008110569A1
|
|
Method for determination of immunomodulatory effect
|
|
AU2005268501A1
|
|
Polypeptide
|
|
NZ531074A
|
|
A thermostable isomerase and use thereof, in particular for producing tagatose
|
|
US7052898B2
|
|
Thermostable isomerase and use hereof, in particular for producing tagatose
|
|
AU2002210401B2
|
|
Fermentation method for production of heterologous gene products in lactic acid bacteria
|
